ID   BRI1_ARATH              Reviewed;        1196 AA.
AC   O22476; C0LGS4;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   18-JUN-2025, entry version 211.
DE   RecName: Full=Protein BRASSINOSTEROID INSENSITIVE 1 {ECO:0000303|PubMed:9298904};
DE            Short=AtBRI1 {ECO:0000303|PubMed:9298904};
DE            EC=2.7.10.1 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000305};
DE   AltName: Full=Brassinosteroid LRR receptor kinase {ECO:0000303|PubMed:9298904};
DE   Flags: Precursor;
GN   Name=BRI1 {ECO:0000303|PubMed:9298904};
GN   OrderedLocusNames=At4g39400 {ECO:0000312|Araport:AT4G39400};
GN   ORFNames=F23K16.30 {ECO:0000312|EMBL:CAB44675.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, MUTANTS BRI1-101;
RP   BRI1-104; BRI1-113 AND BRI1-115, AND MUTAGENESIS OF GLY-611; ALA-1031;
RP   GLY-1048 AND GLU-1078.
RC   STRAIN=cv. Columbia;
RX   PubMed=9298904; DOI=10.1016/s0092-8674(00)80357-8;
RA   Li J., Chory J.;
RT   "A putative leucine-rich repeat receptor kinase involved in brassinosteroid
RT   signal transduction.";
RL   Cell 90:929-938(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, MUTANTS BRI1-5/DWF2-W41;
RP   BRI1-6/BRI1-119/DWF2-399; BRI1-7/DWF2-WM3-2; BRI1-8/DWF2-WM6-2 AND
RP   BRI1-9/DWF2-WMB19, MUTAGENESIS OF CYS-69; GLY-613; GLY-644; SER-662 AND
RP   ARG-983, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. En-2, and cv. Wassilewskija-2;
RX   PubMed=10557222; DOI=10.1104/pp.121.3.743;
RA   Noguchi T., Fujioka S., Choe S., Takatsuto S., Yoshida S., Yuan H.,
RA   Feldmann K.A., Tax F.E.;
RT   "Brassinosteroid-insensitive dwarf mutants of Arabidopsis accumulate
RT   brassinosteroids.";
RL   Plant Physiol. 121:743-752(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, MUTANTS BRI1-1; BRI1-108; BRI1-117 AND BRI1-102, AND
RP   MUTAGENESIS OF THR-750; ALA-909; ARG-983 AND ASP-1139.
RC   STRAIN=cv. Columbia;
RX   PubMed=10938344; DOI=10.1104/pp.123.4.1247;
RA   Friedrichsen D.M., Joazeiro C.A.P., Li J., Hunter T., Chory J.;
RT   "BRASSINOSTEROID-INSENSITIVE-1 is a ubiquitously expressed leucine-rich
RT   repeat receptor serine/threonine kinase.";
RL   Plant Physiol. 123:1247-1256(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=20064227; DOI=10.1186/1471-2164-11-19;
RA   Gou X., He K., Yang H., Yuan T., Lin H., Clouse S.D., Li J.;
RT   "Genome-wide cloning and sequence analysis of leucine-rich repeat receptor-
RT   like protein kinase genes in Arabidopsis thaliana.";
RL   BMC Genomics 11:19-19(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G., Pohl T.,
RA   Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N., Harris B.,
RA   Ansorge W., Brandt P., Grivell L.A., Rieger M., Weichselgartner M.,
RA   de Simone V., Obermaier B., Mache R., Mueller M., Kreis M., Delseny M.,
RA   Puigdomenech P., Watson M., Schmidtheini T., Reichert B., Portetelle D.,
RA   Perez-Alonso M., Boutry M., Bancroft I., Vos P., Hoheisel J.,
RA   Zimmermann W., Wedler H., Ridley P., Langham S.-A., McCullagh B.,
RA   Bilham L., Robben J., van der Schueren J., Grymonprez B., Chuang Y.-J.,
RA   Vandenbussche F., Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R.,
RA   Defoor E., Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W., Mooijman P.,
RA   Klein Lankhorst R., Rose M., Hauf J., Koetter P., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Van den Daele H., De Keyser A., Buysshaert C.,
RA   Gielen J., Villarroel R., De Clercq R., van Montagu M., Rogers J.,
RA   Cronin A., Quail M.A., Bray-Allen S., Clark L., Doggett J., Hall S.,
RA   Kay M., Lennard N., McLay K., Mayes R., Pettett A., Rajandream M.A.,
RA   Lyne M., Benes V., Rechmann S., Borkova D., Bloecker H., Scharfe M.,
RA   Grimm M., Loehnert T.-H., Dose S., de Haan M., Maarse A.C., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D.,
RA   Herzl A., Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R., Schnabl S.,
RA   Hiller R., Schmidt W., Lecharny A., Aubourg S., Chefdor F., Cooke R.,
RA   Berger C., Monfort A., Casacuberta E., Gibbons T., Weber N., Vandenbol M.,
RA   Bargues M., Terol J., Torres A., Perez-Perez A., Purnelle B., Bent E.,
RA   Johnson S., Tacon D., Jesse T., Heijnen L., Schwarz S., Scholler P.,
RA   Heber S., Francs P., Bielke C., Frishman D., Haase D., Lemcke K.,
RA   Mewes H.-W., Stocker S., Zaccaria P., Bevan M., Wilson R.K.,
RA   de la Bastide M., Habermann K., Parnell L., Dedhia N., Gnoj L., Schutz K.,
RA   Huang E., Spiegel L., Sekhon M., Murray J., Sheet P., Cordes M.,
RA   Abu-Threideh J., Stoneking T., Kalicki J., Graves T., Harmon G.,
RA   Edwards J., Latreille P., Courtney L., Cloud J., Abbott A., Scott K.,
RA   Johnson D., Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D., Du H.,
RA   Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C., Antonoiu B.,
RA   Zidanic M., Strong C., Sun H., Lamar B., Yordan C., Ma P., Zhong J.,
RA   Preston R., Vil D., Shekher M., Matero A., Shah R., Swaby I.K.,
RA   O'Shaughnessy A., Rodriguez M., Hoffman J., Till S., Granat S., Shohdy N.,
RA   Hasegawa A., Hameed A., Lodhi M., Johnson A., Chen E., Marra M.A.,
RA   Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana.";
RL   Nature 402:769-777(1999).
RN   [6]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [7]
RP   PHOSPHORYLATION AT SER-838; THR-842; THR-846; SER-858 AND THR-872, AND
RP   MUTAGENESIS OF LYS-911.
RX   PubMed=11027724; DOI=10.1104/pp.124.2.751;
RA   Oh M.-H., Ray W.K., Huber S.C., Asara J.M., Gage D.A., Clouse S.D.;
RT   "Recombinant BRASSINOSTEROID INSENSITIVE 1 receptor-like kinase
RT   autophosphorylates on serine and threonine residues and phosphorylates a
RT   conserved peptide motif in vitro.";
RL   Plant Physiol. 124:751-766(2000).
RN   [8]
RP   STEROID-BINDING.
RX   PubMed=10875920; DOI=10.1126/science.288.5475.2360;
RA   He Z., Wang Z.-Y., Li J., Zhu Q., Lamb C., Ronald P., Chory J.;
RT   "Perception of brassinosteroids by the extracellular domain of the receptor
RT   kinase BRI1.";
RL   Science 288:2360-2363(2000).
RN   [9]
RP   SUBCELLULAR LOCATION, STEROID-BINDING, AND AUTOPHOSPHORYLATION.
RX   PubMed=11268216; DOI=10.1038/35066597;
RA   Wang Z.-Y., Seto H., Fujioka S., Yoshida S., Chory J.;
RT   "BRI1 is a critical component of a plasma-membrane receptor for plant
RT   steroids.";
RL   Nature 410:380-383(2001).
RN   [10]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION, AND INTERACTION WITH BAK1.
RX   PubMed=12150928; DOI=10.1016/s0092-8674(02)00814-0;
RA   Nam K.H., Li J.;
RT   "BRI1/BAK1, a receptor kinase pair mediating brassinosteroid signaling.";
RL   Cell 110:203-212(2002).
RN   [11]
RP   PHOSPHORYLATION, AND INTERACTION WITH BAK1.
RX   PubMed=12150929; DOI=10.1016/s0092-8674(02)00812-7;
RA   Li J., Wen J., Lease K.A., Doke J.T., Tax F.E., Walker J.C.;
RT   "BAK1, an Arabidopsis LRR receptor-like protein kinase, interacts with BRI1
RT   and modulates brassinosteroid signaling.";
RL   Cell 110:213-222(2002).
RN   [12]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH BAK1.
RX   PubMed=15548744; DOI=10.1105/tpc.104.025387;
RA   Russinova E., Borst J.-W., Kwaaitaal M., Cano-Delgado A., Yin Y., Chory J.,
RA   de Vries S.C.;
RT   "Heterodimerization and endocytosis of Arabidopsis brassinosteroid
RT   receptors BRI1 and AtSERK3 (BAK1).";
RL   Plant Cell 16:3216-3229(2004).
RN   [13]
RP   FUNCTION, MUTAGENESIS OF ALA-1031; GLY-1048 AND GLU-1078, AND INTERACTION
RP   WITH TTL.
RC   STRAIN=cv. Columbia;
RX   PubMed=15319482; DOI=10.1105/tpc.104.023903;
RA   Nam K.H., Li J.;
RT   "The Arabidopsis transthyretin-like protein is a potential substrate of
RT   BRASSINOSTEROID-INSENSITIVE 1.";
RL   Plant Cell 16:2406-2417(2004).
RN   [14]
RP   PHOSPHORYLATION AT SER-838; SER-858; THR-872; THR-880; THR-982 AND
RP   SER-1168, INTERACTION WITH BAK1, AND MUTAGENESIS OF SER-838; THR-842;
RP   THR-846; SER-858; THR-872; THR-1039; SER-1042; SER-1044; THR-1045;
RP   THR-1049; SER-1168; SER-1172; 1179-SER-THR-1180 AND SER-1187.
RX   PubMed=15894717; DOI=10.1105/tpc.105.031393;
RA   Wang X., Goshe M.B., Soderblom E.J., Phinney B.S., Kuchar J.A., Li J.,
RA   Asami T., Yoshida S., Huber S.C., Clouse S.D.;
RT   "Identification and functional analysis of in vivo phosphorylation sites of
RT   the Arabidopsis BRASSINOSTEROID-INSENSITIVE1 receptor kinase.";
RL   Plant Cell 17:1685-1703(2005).
RN   [15]
RP   INTERACTION WITH SERK1.
RX   PubMed=16473966; DOI=10.1105/tpc.105.039412;
RA   Karlova R., Boeren S., Russinova E., Aker J., Vervoort J., de Vries S.C.;
RT   "The Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR-LIKE KINASE1 protein
RT   complex includes BRASSINOSTEROID-INSENSITIVE1.";
RL   Plant Cell 18:626-638(2006).
RN   [16]
RP   FUNCTION.
RX   PubMed=17138891; DOI=10.1126/science.1134040;
RA   Belkhadir Y., Chory J.;
RT   "Brassinosteroid signaling: a paradigm for steroid hormone signaling from
RT   the cell surface.";
RL   Science 314:1410-1411(2006).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17578906; DOI=10.1101/gad.1561307;
RA   Geldner N., Hyman D.L., Wang X., Schumacher K., Chory J.;
RT   "Endosomal signaling of plant steroid receptor kinase BRI1.";
RL   Genes Dev. 21:1598-1602(2007).
RN   [18]
RP   GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=17588517; DOI=10.1016/j.molcel.2007.05.015;
RA   Jin H., Yan Z., Nam K.H., Li J.;
RT   "Allele-specific suppression of a defective brassinosteroid receptor
RT   reveals a physiological role of UGGT in ER quality control.";
RL   Mol. Cell 26:821-830(2007).
RN   [19]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=17520012; DOI=10.1371/journal.pone.0000449;
RA   Kwezi L., Meier S., Mungur L., Ruzvidzo O., Irving H., Gehring C.;
RT   "The Arabidopsis thaliana brassinosteroid receptor (AtBRI1) contains a
RT   domain that functions as a guanylyl cyclase in vitro.";
RL   PLoS ONE 2:E449-E449(2007).
RN   [20]
RP   SUBUNIT.
RX   PubMed=17905839; DOI=10.1529/biophysj.107.112003;
RA   Hink M.A., Shah K., Russinova E., de Vries S.C., Visser A.J.;
RT   "Fluorescence fluctuation analysis of Arabidopsis thaliana somatic
RT   embryogenesis receptor-like kinase and brassinosteroid insensitive 1
RT   receptor oligomerization.";
RL   Biophys. J. 94:1052-1062(2008).
RN   [21]
RP   MUTAGENESIS OF GLY-989.
RX   PubMed=18332904; DOI=10.1038/cr.2008.36;
RA   Xu W., Huang J., Li B., Li J., Wang Y.;
RT   "Is kinase activity essential for biological functions of BRI1?";
RL   Cell Res. 18:472-478(2008).
RN   [22]
RP   FUNCTION, PHOSPHORYLATION AT SER-838; THR-846; SER-858; SER-1166 AND
RP   THR-1180, INTERACTION WITH BAK1, AND MUTAGENESIS OF SER-838; THR-842;
RP   THR-846; SER-858; THR-1049; SER-1166; SER-1168; SER-1172; SER-1179 AND
RP   THR-1180.
RX   PubMed=18694562; DOI=10.1016/j.devcel.2008.06.011;
RA   Wang X., Kota U., He K., Blackburn K., Li J., Goshe M.B., Huber S.C.,
RA   Clouse S.D.;
RT   "Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex
RT   impacts early events in brassinosteroid signaling.";
RL   Dev. Cell 15:220-235(2008).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH BSK1 AND BSK3.
RX   PubMed=18653891; DOI=10.1126/science.1156973;
RA   Tang W., Kim T.W., Oses-Prieto J.A., Sun Y., Deng Z., Zhu S., Wang R.,
RA   Burlingame A.L., Wang Z.Y.;
RT   "BSKs mediate signal transduction from the receptor kinase BRI1 in
RT   Arabidopsis.";
RL   Science 321:557-560(2008).
RN   [24]
RP   PHOSPHORYLATION AT SER-887, AND PHOSPHORYLATION OF SERK1.
RX   PubMed=19105183; DOI=10.1002/pmic.200701059;
RA   Karlova R., Boeren S., van Dongen W., Kwaaitaal M., Aker J., Vervoort J.,
RA   de Vries S.C.;
RT   "Identification of in vitro phosphorylation sites in the Arabidopsis
RT   thaliana somatic embryogenesis receptor-like kinases.";
RL   Proteomics 9:368-379(2009).
RN   [25]
RP   FUNCTION, MUTAGENESIS OF TYR-831; TYR-898; TYR-945; TYR-956; TYR-961;
RP   TYR-1052; TYR-1057; TYR-1058; TYR-1070 AND TYR-1072, AUTOPHOSPHORYLATION,
RP   AND PHOSPHORYLATION AT TYR-831 AND TYR-956.
RX   PubMed=19124768; DOI=10.1073/pnas.0810249106;
RA   Oh M.-H., Wang X., Kota U., Goshe M.B., Clouse S.D., Huber S.C.;
RT   "Tyrosine phosphorylation of the BRI1 receptor kinase emerges as a
RT   component of brassinosteroid signaling in Arabidopsis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:658-663(2009).
RN   [26]
RP   INTERACTION WITH CDG1.
RX   PubMed=21855796; DOI=10.1016/j.molcel.2011.05.037;
RA   Kim T.W., Guan S., Burlingame A.L., Wang Z.Y.;
RT   "The CDG1 kinase mediates brassinosteroid signal transduction from BRI1
RT   receptor kinase to BSU1 phosphatase and GSK3-like kinase BIN2.";
RL   Mol. Cell 43:561-571(2011).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH BSK5; BSK6 AND BSK11.
RX   PubMed=23496207; DOI=10.1111/tpj.12175;
RA   Sreeramulu S., Mostizky Y., Sunitha S., Shani E., Nahum H., Salomon D.,
RA   Hayun L.B., Gruetter C., Rauh D., Ori N., Sessa G.;
RT   "BSKs are partially redundant positive regulators of brassinosteroid
RT   signaling in Arabidopsis.";
RL   Plant J. 74:905-919(2013).
RN   [28]
RP   INTERACTION WITH BIK1.
RX   PubMed=23818580; DOI=10.1073/pnas.1302154110;
RA   Lin W., Lu D., Gao X., Jiang S., Ma X., Wang Z., Mengiste T., He P.,
RA   Shan L.;
RT   "Inverse modulation of plant immune and brassinosteroid signaling pathways
RT   by the receptor-like cytoplasmic kinase BIK1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:12114-12119(2013).
RN   [29]
RP   LACK OF INTERACTION WITH CNGC17 AND PSKR1, AND SUBCELLULAR LOCATION.
RX   PubMed=26071421; DOI=10.1105/tpc.15.00306;
RA   Ladwig F., Dahlke R.I., Stuehrwohldt N., Hartmann J., Harter K., Sauter M.;
RT   "Phytosulfokine regulates growth in Arabidopsis through a response module
RT   at the plasma membrane that includes CYCLIC NUCLEOTIDE-GATED CHANNEL17, H+-
RT   ATPase, and BAK1.";
RL   Plant Cell 27:1718-1729(2015).
RN   [30]
RP   INTERACTION WITH B'ALPHA; B'BETA; B'GAMMA AND B'ETA.
RX   PubMed=26517938; DOI=10.1016/j.molp.2015.10.007;
RA   Wang R., Liu M., Yuan M., Oses-Prieto J.A., Cai X., Sun Y.,
RA   Burlingame A.L., Wang Z.Y., Tang W.;
RT   "The brassinosteroid-activated BRI1 receptor kinase is switched off by
RT   dephosphorylation mediated by cytoplasm-localized PP2A B' subunits.";
RL   Mol. Plant 9:148-157(2016).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.52 ANGSTROMS) OF 29-788 IN COMPLEX WITH
RP   BRASSINOLIDE, AND GLYCOSYLATION AT ASN-112; ASN-154; ASN-233; ASN-275;
RP   ASN-351 AND ASN-545.
RX   PubMed=21666665; DOI=10.1038/nature10153;
RA   Hothorn M., Belkhadir Y., Dreux M., Dabi T., Noel J.P., Wilson I.A.,
RA   Chory J.;
RT   "Structural basis of steroid hormone perception by the receptor kinase
RT   BRI1.";
RL   Nature 474:467-471(2011).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 23-784 IN COMPLEX WITH
RP   BRASSINOLIDE, AND GLYCOSYLATION AT ASN-112; ASN-154; ASN-233; ASN-275;
RP   ASN-351; ASN-510; ASN-545 AND ASN-573.
RX   PubMed=21666666; DOI=10.1038/nature10178;
RA   She J., Han Z., Kim T.W., Wang J., Cheng W., Chang J., Shi S., Wang J.,
RA   Yang M., Wang Z.Y., Chai J.;
RT   "Structural insight into brassinosteroid perception by BRI1.";
RL   Nature 474:472-476(2011).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 29-788 IN COMPLEX WITH
RP   BRASSINOLIDE AND SERK1, INTERACTION WITH SERK1, AND GLYCOSYLATION AT
RP   ASN-112; ASN-154; ASN-233; ASN-275; ASN-351; ASN-545 AND ASN-573.
RX   PubMed=23929946; DOI=10.1126/science.1242468;
RA   Santiago J., Henzler C., Hothorn M.;
RT   "Molecular mechanism for plant steroid receptor activation by somatic
RT   embryogenesis co-receptor kinases.";
RL   Science 341:889-892(2013).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 865-1160 IN COMPLEX WITH ATP, AND
RP   GLYCOSYLATION AT ASN-154; ASN-275 AND ASN-545.
RX   PubMed=24461462; DOI=10.1111/tpj.12445;
RA   Bojar D., Martinez J., Santiago J., Rybin V., Bayliss R., Hothorn M.;
RT   "Crystal structures of the phosphorylated BRI1 kinase domain and
RT   implications for brassinosteroid signal initiation.";
RL   Plant J. 78:31-43(2014).
CC   -!- FUNCTION: Receptor with a dual specificity kinase activity acting on
CC       both serine/threonine- and tyrosine-containing substrates. Regulates,
CC       in response to brassinosteroid binding, a signaling cascade involved in
CC       plant development, including expression of light- and stress-regulated
CC       genes, promotion of cell elongation, normal leaf and chloroplast
CC       senescence, and flowering. Binds brassinolide (BL), and less
CC       effectively castasterone (CS), but not 2,3,22,23-O-
CC       tetramethylbrassinolide or ecdysone. May be involved in a feedback
CC       regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-
CC       associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL)
CC       and SERK1 on 'Ser-299' and 'Thr-462' in vitro (PubMed:15319482). May
CC       have a guanylyl cyclase activity (PubMed:10557222, PubMed:10938344,
CC       PubMed:17138891, PubMed:17520012, PubMed:18694562, PubMed:19124768).
CC       Phosphorylates BSK1, BSK2 and BSK3 in vitro (PubMed:18653891).
CC       Phosphorylates BSK1, BSK3, BSK5, BSK6, BSK8 and BSK11 in vitro
CC       (PubMed:23496207). {ECO:0000269|PubMed:10557222,
CC       ECO:0000269|PubMed:10938344, ECO:0000269|PubMed:15319482,
CC       ECO:0000269|PubMed:17138891, ECO:0000269|PubMed:17520012,
CC       ECO:0000269|PubMed:18653891, ECO:0000269|PubMed:18694562,
CC       ECO:0000269|PubMed:19124768, ECO:0000269|PubMed:23496207}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP +
CC         H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] +
CC         ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] +
CC         ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:20101, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:61978, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10027};
CC   -!- ACTIVITY REGULATION: Activated by Ser and Thr phosphorylation.
CC   -!- SUBUNIT: Monomer or homodimer in the plasma membrane. Heterodimer with
CC       BAK1 in the endosomes. Interacts with SERK1 and TTL in a kinase-
CC       dependent manner (PubMed:15319482). Bind to SERK1 in a brassinolide-
CC       dependent manner (PubMed:23929946). Component of the SERK1 signaling
CC       complex, composed of KAPP, CDC48A, GRF6 or GRF7, SERK1, SERK2,
CC       SERK3/BAK1 and BRI1. Interacts with CDG1 (PubMed:21855796). No
CC       interactions with PSKR1 or CNGC17 (PubMed:26071421). Interacts with
CC       BIK1 (PubMed:23818580). Interacts with B'ALPHA, B'BETA, B'GAMMA and
CC       B'ETA (PubMed:26517938). Interacts with BSK1 and BSK3
CC       (PubMed:18653891). Interacts with BSK5, BSK6 and BSK11
CC       (PubMed:23496207). {ECO:0000269|PubMed:12150928,
CC       ECO:0000269|PubMed:12150929, ECO:0000269|PubMed:15319482,
CC       ECO:0000269|PubMed:15548744, ECO:0000269|PubMed:15894717,
CC       ECO:0000269|PubMed:16473966, ECO:0000269|PubMed:17905839,
CC       ECO:0000269|PubMed:18653891, ECO:0000269|PubMed:18694562,
CC       ECO:0000269|PubMed:21855796, ECO:0000269|PubMed:23496207,
CC       ECO:0000269|PubMed:23818580, ECO:0000269|PubMed:23929946,
CC       ECO:0000269|PubMed:26071421, ECO:0000269|PubMed:26517938}.
CC   -!- INTERACTION:
CC       O22476; Q94F62: BAK1; NbExp=9; IntAct=EBI-1797828, EBI-617138;
CC       O22476; O65440-2: BAM3; NbExp=3; IntAct=EBI-1797828, EBI-20653325;
CC       O22476; O22476: BRI1; NbExp=4; IntAct=EBI-1797828, EBI-1797828;
CC       O22476; Q944A7: BSK1; NbExp=4; IntAct=EBI-1797828, EBI-1797846;
CC       O22476; Q8W4L3: BSK3; NbExp=2; IntAct=EBI-1797828, EBI-1797930;
CC       O22476; Q6XAT2: ERL2; NbExp=2; IntAct=EBI-1797828, EBI-16895926;
CC       O22476; Q9ZVD4: LRR-RLK; NbExp=2; IntAct=EBI-1797828, EBI-20651739;
CC       O22476; Q9S7I6: RPK2; NbExp=2; IntAct=EBI-1797828, EBI-16940204;
CC       O22476; Q94AG2: SERK1; NbExp=7; IntAct=EBI-1797828, EBI-1555537;
CC       O22476; Q8RWZ1: SUB; NbExp=2; IntAct=EBI-1797828, EBI-17072125;
CC       O22476; Q9LVM5: TTL; NbExp=3; IntAct=EBI-1797828, EBI-1803584;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26071421};
CC       Single-pass type I membrane protein {ECO:0000305}. Endosome membrane;
CC       Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously.
CC       {ECO:0000269|PubMed:10938344, ECO:0000269|PubMed:9298904}.
CC   -!- DEVELOPMENTAL STAGE: Expressed constitutively in either dark- or light-
CC       grown seedlings.
CC   -!- DOMAIN: Contains one leucine-zipper motif and two pairs of
CC       conservatively spaced Cys (Cys pair 1 and 2) involved in forming
CC       heterodimers. {ECO:0000269|PubMed:17520012}.
CC   -!- DOMAIN: A 70 amino acid island between the 21st and the 22th LRR is
CC       essential for the binding of brassinosteroids.
CC       {ECO:0000269|PubMed:21666665}.
CC   -!- DOMAIN: The JM domain (815-883) is a positive regulator of kinase
CC       activity and is required for Tyr phosphorylation.
CC       {ECO:0000269|PubMed:17520012}.
CC   -!- DOMAIN: A guanylyl cyclase domain (1021-1134) having an in vitro
CC       activity is included in the C-terminal kinase domain.
CC       {ECO:0000269|PubMed:17520012}.
CC   -!- PTM: Autophosphorylated on Tyr-831, Tyr-956 and maybe Tyr-1072.
CC       Phosphorylated on at least 12 sites, with a preference for Ser
CC       residues. Transphosphorylated on Ser-887 by SERK1 and on Ser-838, Thr-
CC       846, Ser-858 and Ser-1166 by BAK1. Phosphorylation on Ser-1166 enhances
CC       the kinase activity. {ECO:0000269|PubMed:11027724,
CC       ECO:0000269|PubMed:12150928, ECO:0000269|PubMed:12150929,
CC       ECO:0000269|PubMed:15894717, ECO:0000269|PubMed:18694562,
CC       ECO:0000269|PubMed:19105183, ECO:0000269|PubMed:19124768}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:17588517}.
CC   -!- DISRUPTION PHENOTYPE: Dwarf phenotype and aberrant leaf shape.
CC       {ECO:0000269|PubMed:10557222}.
CC   -!- MISCELLANEOUS: Binding of brassinosteroid induces intramolecular
CC       autophosphorylation of BRI1. Interaction with BAK1 activates both
CC       receptor kinases and the full activation of either receptor kinase
CC       requires transphosphorylation by their partners. Optimum in vitro
CC       phosphorylation of the substrate requires Arg or Lys residues at P-3,
CC       P-4, and P+5 (relative to the phosphorylated amino acid at P=0).
CC       Homodimerizes in the absence of ligand and binds brassinosteroid in the
CC       absence of its coreceptor BAK1.
CC   -!- MISCELLANEOUS: The bri1-9 mutation produces a fully active protein with
CC       a subtle conformational change that is recognized for reglucosylation
CC       by UGGT, resulting in its endoplasmic reticulum retention via
CC       Glc(1)Man(9)GlcNAc(2)-calreticulin/calnexin interaction.
CC       {ECO:0000305|PubMed:17588517}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF017056; AAC49810.1; -; Genomic_DNA.
DR   EMBL; FJ708766; ACN59359.1; -; mRNA.
DR   EMBL; AL078620; CAB44675.1; -; Genomic_DNA.
DR   EMBL; AL161595; CAB80603.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE87069.1; -; Genomic_DNA.
DR   PIR; T09356; T09356.
DR   RefSeq; NP_195650.1; NM_120100.3.
DR   PDB; 3RGX; X-ray; 2.47 A; A=23-784.
DR   PDB; 3RGZ; X-ray; 2.28 A; A=23-784.
DR   PDB; 3RIZ; X-ray; 2.52 A; A=29-788.
DR   PDB; 3RJ0; X-ray; 2.54 A; A=29-788.
DR   PDB; 4LSA; X-ray; 2.50 A; A=29-788.
DR   PDB; 4LSX; X-ray; 3.30 A; A/B=29-788.
DR   PDB; 4M7E; X-ray; 3.60 A; A/B=24-784.
DR   PDB; 4OH4; X-ray; 2.25 A; A/B=863-1172.
DR   PDB; 4Q5J; X-ray; 2.77 A; A/B=863-1180.
DR   PDB; 5LPB; X-ray; 1.98 A; A=865-1160.
DR   PDB; 5LPV; X-ray; 2.70 A; A=865-1160.
DR   PDB; 5LPW; X-ray; 2.43 A; A=865-1160.
DR   PDB; 5LPY; X-ray; 2.30 A; A=865-1160.
DR   PDB; 5LPZ; X-ray; 2.48 A; A=865-1196.
DR   PDB; 6FIF; X-ray; 2.54 A; A=1-788.
DR   PDBsum; 3RGX; -.
DR   PDBsum; 3RGZ; -.
DR   PDBsum; 3RIZ; -.
DR   PDBsum; 3RJ0; -.
DR   PDBsum; 4LSA; -.
DR   PDBsum; 4LSX; -.
DR   PDBsum; 4M7E; -.
DR   PDBsum; 4OH4; -.
DR   PDBsum; 4Q5J; -.
DR   PDBsum; 5LPB; -.
DR   PDBsum; 5LPV; -.
DR   PDBsum; 5LPW; -.
DR   PDBsum; 5LPY; -.
DR   PDBsum; 5LPZ; -.
DR   PDBsum; 6FIF; -.
DR   AlphaFoldDB; O22476; -.
DR   SMR; O22476; -.
DR   BioGRID; 15375; 45.
DR   DIP; DIP-45997N; -.
DR   FunCoup; O22476; 1624.
DR   IntAct; O22476; 32.
DR   STRING; 3702.O22476; -.
DR   TCDB; 1.A.87.2.6; the mechanosensitive calcium channel (mca) family.
DR   GlyCosmos; O22476; 14 sites, No reported glycans.
DR   GlyGen; O22476; 17 sites.
DR   iPTMnet; O22476; -.
DR   PaxDb; 3702-AT4G39400.1; -.
DR   ProteomicsDB; 240703; -.
DR   EnsemblPlants; AT4G39400.1; AT4G39400.1; AT4G39400.
DR   GeneID; 830095; -.
DR   Gramene; AT4G39400.1; AT4G39400.1; AT4G39400.
DR   KEGG; ath:AT4G39400; -.
DR   Araport; AT4G39400; -.
DR   TAIR; AT4G39400; BRI1.
DR   eggNOG; ENOG502QRF2; Eukaryota.
DR   HOGENOM; CLU_000288_22_4_1; -.
DR   InParanoid; O22476; -.
DR   OMA; GWVKLHA; -.
DR   PhylomeDB; O22476; -.
DR   EvolutionaryTrace; O22476; -.
DR   PRO; PR:O22476; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; O22476; baseline and differential.
DR   GO; GO:0005768; C:endosome; IDA:TAIR.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0032991; C:protein-containing complex; IPI:TAIR.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:TAIR.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:TAIR.
DR   GO; GO:0004672; F:protein kinase activity; IDA:TAIR.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:TAIR.
DR   GO; GO:0005496; F:steroid binding; IDA:TAIR.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0048657; P:anther wall tapetum cell differentiation; IMP:TAIR.
DR   GO; GO:0010268; P:brassinosteroid homeostasis; IEP:TAIR.
DR   GO; GO:0009742; P:brassinosteroid mediated signaling pathway; IMP:TAIR.
DR   GO; GO:0009729; P:detection of brassinosteroid stimulus; IMP:TAIR.
DR   GO; GO:0048366; P:leaf development; IMP:TAIR.
DR   GO; GO:0010584; P:pollen exine formation; IMP:TAIR.
DR   GO; GO:0009911; P:positive regulation of flower development; IGI:TAIR.
DR   GO; GO:0010224; P:response to UV-B; IGI:TAIR.
DR   GO; GO:0090351; P:seedling development; IMP:UniProtKB.
DR   CDD; cd14066; STKc_IRAK; 1.
DR   FunFam; 1.10.510.10:FF:000291; Brassinosteroid LRR receptor kinase; 1.
DR   FunFam; 3.80.10.10:FF:000125; Brassinosteroid LRR receptor kinase; 1.
DR   FunFam; 3.80.10.10:FF:000111; LRR receptor-like serine/threonine-protein kinase ERECTA; 1.
DR   FunFam; 3.30.1490.310:FF:000001; Serine/threonine-protein kinase BRI1-like 1; 1.
DR   FunFam; 3.30.200.20:FF:000150; serine/threonine-protein kinase BRI1-like 2; 1.
DR   Gene3D; 3.30.1490.310; -; 1.
DR   Gene3D; 3.30.200.20; Phosphorylase Kinase, domain 1; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR045381; BRI1_island_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR013210; LRR_N_plant-typ.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR27000; LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE FAMILY PROTEIN-RELATED; 1.
DR   PANTHER; PTHR27000:SF800; OS11G0197000 PROTEIN; 1.
DR   Pfam; PF20141; Island; 1.
DR   Pfam; PF00560; LRR_1; 9.
DR   Pfam; PF13855; LRR_8; 2.
DR   Pfam; PF08263; LRRNT_2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00019; LEURICHRPT.
DR   SMART; SM00369; LRR_TYP; 7.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF52058; L domain-like; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF52047; RNI-like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Brassinosteroid signaling pathway;
KW   Cell membrane; Endosome; Glycoprotein; Kinase; Leucine-rich repeat;
KW   Lipid-binding; Membrane; Nucleotide-binding; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Signal;
KW   Steroid-binding; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1196
FT                   /note="Protein BRASSINOSTEROID INSENSITIVE 1"
FT                   /id="PRO_0000024305"
FT   TRANSMEM        793..813
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REPEAT          71..98
FT                   /note="LRR 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          99..121
FT                   /note="LRR 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          122..146
FT                   /note="LRR 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          148..169
FT                   /note="LRR 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          172..197
FT                   /note="LRR 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          199..221
FT                   /note="LRR 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          222..244
FT                   /note="LRR 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          245..268
FT                   /note="LRR 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          269..290
FT                   /note="LRR 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          291..314
FT                   /note="LRR 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          316..338
FT                   /note="LRR 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          339..363
FT                   /note="LRR 12"
FT                   /evidence="ECO:0000255"
FT   REPEAT          364..388
FT                   /note="LRR 13"
FT                   /evidence="ECO:0000255"
FT   REPEAT          390..413
FT                   /note="LRR 14"
FT                   /evidence="ECO:0000255"
FT   REPEAT          415..439
FT                   /note="LRR 15"
FT                   /evidence="ECO:0000255"
FT   REPEAT          441..463
FT                   /note="LRR 16"
FT                   /evidence="ECO:0000255"
FT   REPEAT          464..487
FT                   /note="LRR 17"
FT                   /evidence="ECO:0000255"
FT   REPEAT          488..511
FT                   /note="LRR 18"
FT                   /evidence="ECO:0000255"
FT   REPEAT          513..535
FT                   /note="LRR 19"
FT                   /evidence="ECO:0000255"
FT   REPEAT          536..559
FT                   /note="LRR 20"
FT                   /evidence="ECO:0000255"
FT   REPEAT          561..583
FT                   /note="LRR 21"
FT                   /evidence="ECO:0000255"
FT   REPEAT          653..677
FT                   /note="LRR 22"
FT                   /evidence="ECO:0000255"
FT   REPEAT          678..701
FT                   /note="LRR 23"
FT                   /evidence="ECO:0000255"
FT   REPEAT          702..725
FT                   /note="LRR 24"
FT                   /evidence="ECO:0000255"
FT   REPEAT          727..750
FT                   /note="LRR 25"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          883..1158
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          640..642
FT                   /note="SERK1 binding"
FT                   /evidence="ECO:0000269|PubMed:23929946,
FT                   ECO:0007744|PDB:4LSX"
FT   REGION          726..729
FT                   /note="SERK1 binding"
FT                   /evidence="ECO:0000269|PubMed:23929946,
FT                   ECO:0007744|PDB:4LSX"
FT   REGION          746..750
FT                   /note="SERK1 binding"
FT                   /evidence="ECO:0000269|PubMed:23929946,
FT                   ECO:0007744|PDB:4LSX"
FT   MOTIF           62..69
FT                   /note="Cys pair 1"
FT   MOTIF           763..770
FT                   /note="Cys pair 2"
FT   ACT_SITE        1009
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         597
FT                   /ligand="brassinolide"
FT                   /ligand_id="ChEBI:CHEBI:28277"
FT                   /evidence="ECO:0000269|PubMed:21666666,
FT                   ECO:0000269|PubMed:23929946"
FT   BINDING         642
FT                   /ligand="brassinolide"
FT                   /ligand_id="ChEBI:CHEBI:28277"
FT                   /evidence="ECO:0000269|PubMed:23929946"
FT   BINDING         647
FT                   /ligand="brassinolide"
FT                   /ligand_id="ChEBI:CHEBI:28277"
FT                   /evidence="ECO:0000269|PubMed:21666665,
FT                   ECO:0000269|PubMed:21666666, ECO:0000269|PubMed:23929946"
FT   BINDING         705
FT                   /ligand="brassinolide"
FT                   /ligand_id="ChEBI:CHEBI:28277"
FT                   /evidence="ECO:0000269|PubMed:21666666"
FT   BINDING         889..897
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         911
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:24461462"
FT   BINDING         957..959
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:24461462"
FT   BINDING         963..966
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:24461462"
FT   BINDING         1009..1014
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:24461462"
FT   BINDING         1027
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:24461462"
FT   SITE            705
FT                   /note="Interacts with SERK1"
FT                   /evidence="ECO:0000269|PubMed:23929946,
FT                   ECO:0007744|PDB:4LSX"
FT   SITE            765
FT                   /note="Interacts with SERK1"
FT                   /evidence="ECO:0000269|PubMed:23929946,
FT                   ECO:0007744|PDB:4LSX"
FT   MOD_RES         831
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MOD_RES         838
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11027724,
FT                   ECO:0000269|PubMed:15894717, ECO:0000269|PubMed:18694562"
FT   MOD_RES         842
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11027724"
FT   MOD_RES         846
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11027724,
FT                   ECO:0000269|PubMed:18694562"
FT   MOD_RES         851
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         858
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11027724,
FT                   ECO:0000269|PubMed:15894717, ECO:0000269|PubMed:18694562"
FT   MOD_RES         872
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11027724,
FT                   ECO:0000269|PubMed:15894717"
FT   MOD_RES         880
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MOD_RES         887
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19105183"
FT   MOD_RES         891
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         956
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MOD_RES         981
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         982
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MOD_RES         1035
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1039
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1042
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1044
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9M0G7, ECO:0000255"
FT   MOD_RES         1045
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1049
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1052
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:C0LGT6"
FT   MOD_RES         1060
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1072
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18694562"
FT   MOD_RES         1168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MOD_RES         1169
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1172
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1180
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:18694562"
FT   MOD_RES         1187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        112
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666665,
FT                   ECO:0000269|PubMed:21666666, ECO:0000269|PubMed:23929946"
FT   CARBOHYD        154
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666665,
FT                   ECO:0000269|PubMed:21666666, ECO:0000269|PubMed:23929946,
FT                   ECO:0000269|PubMed:24461462"
FT   CARBOHYD        233
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666665,
FT                   ECO:0000269|PubMed:21666666, ECO:0000269|PubMed:23929946"
FT   CARBOHYD        275
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666665,
FT                   ECO:0000269|PubMed:21666666, ECO:0000269|PubMed:23929946,
FT                   ECO:0000269|PubMed:24461462"
FT   CARBOHYD        351
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666665,
FT                   ECO:0000269|PubMed:21666666, ECO:0000269|PubMed:23929946"
FT   CARBOHYD        387
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        401
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        438
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        510
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666666"
FT   CARBOHYD        545
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666665,
FT                   ECO:0000269|PubMed:21666666, ECO:0000269|PubMed:23929946,
FT                   ECO:0000269|PubMed:24461462"
FT   CARBOHYD        573
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21666666,
FT                   ECO:0000269|PubMed:23929946"
FT   CARBOHYD        636
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        653
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        737
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         69
FT                   /note="C->Y: In bri1-5; brassinosteroid-insensitive
FT                   semi-dwarf mutant."
FT                   /evidence="ECO:0000269|PubMed:10557222"
FT   MUTAGEN         611
FT                   /note="G->E: In bri1-113; brassinosteroid-insensitive
FT                   semi-dwarf mutant."
FT                   /evidence="ECO:0000269|PubMed:9298904"
FT   MUTAGEN         613
FT                   /note="G->S: In bri1-7; brassinosteroid-insensitive
FT                   semi-dwarf mutant."
FT                   /evidence="ECO:0000269|PubMed:10557222"
FT   MUTAGEN         644
FT                   /note="G->D: In bri1-6; brassinosteroid-insensitive
FT                   semi-dwarf mutant."
FT                   /evidence="ECO:0000269|PubMed:10557222"
FT   MUTAGEN         662
FT                   /note="S->F: In bri1-9; brassinosteroid-insensitive
FT                   semi-dwarf mutant."
FT                   /evidence="ECO:0000269|PubMed:10557222"
FT   MUTAGEN         750
FT                   /note="T->I: In bri1-102; brassinosteroid-insensitive dwarf
FT                   mutant."
FT                   /evidence="ECO:0000269|PubMed:10938344"
FT   MUTAGEN         831
FT                   /note="Y->D,E: No effect on kinase activity, flowering time
FT                   or leaf size, but altered leaf shape."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         831
FT                   /note="Y->F: No effect on kinase activity but altered
FT                   flowering time and leaf size and shape."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         838
FT                   /note="S->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         838
FT                   /note="S->D: Increased kinase activity; when associated
FT                   with D-842; D-846 and D-858."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         842
FT                   /note="T->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         842
FT                   /note="T->D: Increased kinase activity; when associated
FT                   with D-838; D-846 and D-858."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         846
FT                   /note="T->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         846
FT                   /note="T->D: Increased kinase activity; when associated
FT                   with D-838; D-842 and D-858."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         858
FT                   /note="S->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         858
FT                   /note="S->D: Increased kinase activity; when associated
FT                   with D-838; D-842 and D-846."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         872
FT                   /note="T->A: 10-fold increase in peptide phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MUTAGEN         898
FT                   /note="Y->F: No effect on kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         909
FT                   /note="A->T: In bri1-1; brassinosteroid-insensitive dwarf
FT                   mutant."
FT                   /evidence="ECO:0000269|PubMed:10938344"
FT   MUTAGEN         911
FT                   /note="K->E: Loss of kinase activity; dwarf mutant."
FT                   /evidence="ECO:0000269|PubMed:11027724"
FT   MUTAGEN         945
FT                   /note="Y->F: No effect on kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         956
FT                   /note="Y->F: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         961
FT                   /note="Y->F: No effect on kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         983
FT                   /note="R->N: In bri1-8; brassinosteroid-insensitive dwarf
FT                   mutant."
FT                   /evidence="ECO:0000269|PubMed:10557222"
FT   MUTAGEN         983
FT                   /note="R->Q: In bri1-108; brassinosteroid-insensitive dwarf
FT                   mutant."
FT                   /evidence="ECO:0000269|PubMed:10938344"
FT   MUTAGEN         989
FT                   /note="G->I: In bri1-301; impaired kinase activity and loss
FT                   of autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:18332904"
FT   MUTAGEN         1031
FT                   /note="A->T: In bri1-104; brassinosteroid-insensitive dwarf
FT                   mutant and slightly reduced activity, but no effect on
FT                   interaction with TTL."
FT                   /evidence="ECO:0000269|PubMed:15319482,
FT                   ECO:0000269|PubMed:9298904"
FT   MUTAGEN         1039
FT                   /note="T->A: Abolishes peptide phosphorylation, and to a
FT                   lower level autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MUTAGEN         1042
FT                   /note="S->A: Abolishes peptide phosphorylation, and to a
FT                   lower level autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MUTAGEN         1044
FT                   /note="S->A: Abolishes peptide phosphorylation, and
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MUTAGEN         1045
FT                   /note="T->A: Abolishes peptide phosphorylation, and
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MUTAGEN         1048
FT                   /note="G->D: In bri1-115; brassinosteroid-insensitive dwarf
FT                   mutant, reduced activity and no interaction with TTL."
FT                   /evidence="ECO:0000269|PubMed:15319482,
FT                   ECO:0000269|PubMed:9298904"
FT   MUTAGEN         1049
FT                   /note="T->A: Abolishes peptide phosphorylation, and
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1049
FT                   /note="T->D: Loss of kinase activity and brassinosteroid
FT                   signaling."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1052
FT                   /note="Y->F: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         1057
FT                   /note="Y->F: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         1058
FT                   /note="Y->F: No effect on kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         1070
FT                   /note="Y->F: No effect on kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         1072
FT                   /note="Y->F: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19124768"
FT   MUTAGEN         1078
FT                   /note="E->K: In bri1-101; brassinosteroid-insensitive dwarf
FT                   mutant, lost activity and no interaction with TTL."
FT                   /evidence="ECO:0000269|PubMed:15319482,
FT                   ECO:0000269|PubMed:9298904"
FT   MUTAGEN         1139
FT                   /note="D->N: In bri1-117; brassinosteroid-insensitive dwarf
FT                   mutant."
FT                   /evidence="ECO:0000269|PubMed:10938344"
FT   MUTAGEN         1166
FT                   /note="S->D: Increased kinase activity; when associated
FT                   with D-1168; D-1172; D-1179 and D-1180."
FT                   /evidence="ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1168
FT                   /note="S->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1168
FT                   /note="S->D: Increased kinase activity; when associated
FT                   with D-1166; D-1172; D-1179 and D-1180."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1172
FT                   /note="S->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1172
FT                   /note="S->D: Increased kinase activity; when associated
FT                   with D-1166; D-1168; D-1179 and D-1180."
FT                   /evidence="ECO:0000269|PubMed:15894717,
FT                   ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1179..1180
FT                   /note="ST->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   MUTAGEN         1179
FT                   /note="S->D: Increased kinase activity; when associated
FT                   with D-1166; D-1168; D-1172 and D-1180."
FT                   /evidence="ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1180
FT                   /note="T->D: Increased kinase activity; when associated
FT                   with D-1166; D-1168; D-1172 and D-1179."
FT                   /evidence="ECO:0000269|PubMed:18694562"
FT   MUTAGEN         1187
FT                   /note="S->A: Decreases peptide phosphorylation, but no
FT                   effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15894717"
FT   HELIX           32..43
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           49..51
FT                   /evidence="ECO:0007829|PDB:3RIZ"
FT   STRAND          57..59
FT                   /evidence="ECO:0007829|PDB:3RGX"
FT   HELIX           61..63
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          67..70
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          73..78
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           88..94
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   TURN            95..97
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          131..137
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           138..146
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          176..179
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          182..184
FT                   /evidence="ECO:0007829|PDB:3RGX"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           190..195
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          204..206
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          209..214
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          226..228
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          249..251
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           261..264
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   TURN            265..267
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          273..275
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          295..297
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          300..306
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           309..314
FT                   /evidence="ECO:0007829|PDB:3RGX"
FT   TURN            315..317
FT                   /evidence="ECO:0007829|PDB:3RGX"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          325..330
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           334..338
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          344..346
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          349..355
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           358..361
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          369..371
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          374..379
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           385..388
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   TURN            389..391
FT                   /evidence="ECO:0007829|PDB:3RGX"
FT   STRAND          393..396
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          399..405
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   TURN            408..411
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          413..415
FT                   /evidence="ECO:0007829|PDB:4LSA"
FT   STRAND          420..422
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          425..431
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           434..438
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          444..446
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           458..462
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          468..470
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           482..486
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          492..494
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          497..500
FT                   /evidence="ECO:0007829|PDB:3RIZ"
FT   HELIX           506..510
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          516..518
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          525..527
FT                   /evidence="ECO:0007829|PDB:3RIZ"
FT   HELIX           530..534
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          540..542
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          549..551
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           554..558
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          564..566
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          569..575
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           578..581
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   TURN            582..585
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   TURN            591..594
FT                   /evidence="ECO:0007829|PDB:4LSA"
FT   STRAND          596..601
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          611..617
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           623..631
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          641..645
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          651..654
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          658..660
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          663..668
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           672..676
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          682..684
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          687..693
FT                   /evidence="ECO:0007829|PDB:3RGX"
FT   HELIX           696..700
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          706..708
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          715..717
FT                   /evidence="ECO:0007829|PDB:3RGX"
FT   HELIX           720..724
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          729..732
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          735..741
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          744..747
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           748..750
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           753..756
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   STRAND          761..764
FT                   /evidence="ECO:0007829|PDB:3RGZ"
FT   HELIX           873..879
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   TURN            880..883
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           885..887
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          888..892
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          895..901
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          907..913
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   TURN            916..918
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           919..929
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           931..933
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          942..948
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          951..957
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           964..969
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           971..973
FT                   /evidence="ECO:0007829|PDB:5LPY"
FT   HELIX           980..999
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          1001..1006
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1012..1014
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          1015..1017
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          1023..1025
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          1032..1034
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   TURN            1050..1052
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1055..1058
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   STRAND          1060..1063
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1065..1081
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   TURN            1089..1093
FT                   /evidence="ECO:0007829|PDB:4OH4"
FT   HELIX           1096..1103
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1108..1110
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1114..1117
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1121..1123
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1124..1137
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1142..1144
FT                   /evidence="ECO:0007829|PDB:5LPB"
FT   HELIX           1148..1159
FT                   /evidence="ECO:0007829|PDB:5LPB"
SQ   SEQUENCE   1196 AA;  130543 MW;  C7FBA1C21294E600 CRC64;
     MKTFSSFFLS VTTLFFFSFF SLSFQASPSQ SLYREIHQLI SFKDVLPDKN LLPDWSSNKN
     PCTFDGVTCR DDKVTSIDLS SKPLNVGFSA VSSSLLSLTG LESLFLSNSH INGSVSGFKC
     SASLTSLDLS RNSLSGPVTT LTSLGSCSGL KFLNVSSNTL DFPGKVSGGL KLNSLEVLDL
     SANSISGANV VGWVLSDGCG ELKHLAISGN KISGDVDVSR CVNLEFLDVS SNNFSTGIPF
     LGDCSALQHL DISGNKLSGD FSRAISTCTE LKLLNISSNQ FVGPIPPLPL KSLQYLSLAE
     NKFTGEIPDF LSGACDTLTG LDLSGNHFYG AVPPFFGSCS LLESLALSSN NFSGELPMDT
     LLKMRGLKVL DLSFNEFSGE LPESLTNLSA SLLTLDLSSN NFSGPILPNL CQNPKNTLQE
     LYLQNNGFTG KIPPTLSNCS ELVSLHLSFN YLSGTIPSSL GSLSKLRDLK LWLNMLEGEI
     PQELMYVKTL ETLILDFNDL TGEIPSGLSN CTNLNWISLS NNRLTGEIPK WIGRLENLAI
     LKLSNNSFSG NIPAELGDCR SLIWLDLNTN LFNGTIPAAM FKQSGKIAAN FIAGKRYVYI
     KNDGMKKECH GAGNLLEFQG IRSEQLNRLS TRNPCNITSR VYGGHTSPTF DNNGSMMFLD
     MSYNMLSGYI PKEIGSMPYL FILNLGHNDI SGSIPDEVGD LRGLNILDLS SNKLDGRIPQ
     AMSALTMLTE IDLSNNNLSG PIPEMGQFET FPPAKFLNNP GLCGYPLPRC DPSNADGYAH
     HQRSHGRRPA SLAGSVAMGL LFSFVCIFGL ILVGREMRKR RRKKEAELEM YAEGHGNSGD
     RTANNTNWKL TGVKEALSIN LAAFEKPLRK LTFADLLQAT NGFHNDSLIG SGGFGDVYKA
     ILKDGSAVAI KKLIHVSGQG DREFMAEMET IGKIKHRNLV PLLGYCKVGD ERLLVYEFMK
     YGSLEDVLHD PKKAGVKLNW STRRKIAIGS ARGLAFLHHN CSPHIIHRDM KSSNVLLDEN
     LEARVSDFGM ARLMSAMDTH LSVSTLAGTP GYVPPEYYQS FRCSTKGDVY SYGVVLLELL
     TGKRPTDSPD FGDNNLVGWV KQHAKLRISD VFDPELMKED PALEIELLQH LKVAVACLDD
     RAWRRPTMVQ VMAMFKEIQA GSGIDSQSTI RSIEDGGFST IEMVDMSIKE VPEGKL
//
